Septhemba 2022: I-Ibrutinib (Imbruvica, Pharmacyclics LLC) yagunyazwa yi-Food and Drug Administration ukuze isetshenziswe ezigulini zezingane ezine-graft versus host disease (cGVHD) ezingaphansi konyaka owodwa ubudala futhi ezihlulekile.
Mashi 2022: I-Abatacept (i-Orencia, i-Bristol-Myers Squibb Company) igunyazwe yi-Food and Drug Administration ukuze kuvinjwe isifo esiyingozi se-graft versus host (aGVHD) kubantu abadala nasezigulini zezingane ezineminyaka engu-2 ubudala.
Okthoba 2021: Ngemva kokuhluleka komugqa owodwa noma emibili ye-systemic therapy, i-Food and Drug Administration igunyaze i-ruxolitinib (Jakafi, Incyte Corp.) ye-graft-versus-host disease (cGVHD) kubantu abadala nasezinganeni ezineminyaka engu-12 nangaphezulu...
Agasti 2021: Ngemuva kokwehluleka okungenani kwemigqa emibili yokwelashwa kwesistimu, i-Food and Drug Administration igunyaze i-belumosudil (i-Rezurock, i-Kadmon Pharmaceuticals, LLC), i-kinase inhibitor, yeziguli zabantu abadala kanye nezingane eziyishumi nambili ..
Julayi 2021: I-Beta-thalassemia yisimo esizuzwe njengefa esibangelwa ukuguquka kofuzo okuhilelekile ekukhiqizeni ingxenye ye-hemoglobin, iphrotheni ehambisa umoya-mpilo kuwo wonke umzimba. Lezi zinguquko zivimbela ..
Ukufakelwa komnkantsha eNdiya Ukufakelwa kwe-bone marrow stem cell eNdiya kwenziwa ezinye zezikhungo ezihamba phambili zomdlavuza. Kuze kube manje, ngaphezu kwe-10,000 ukufakelwa kwe-bone marrow stem cell okuphumelelayo okwenziwe eNdiya. ..
Le ndaba imayelana nokufakelwa komnkantsha eNdiya. U-Mukhtar, wase-Assela e-Ethiopia, unesifo esibulalayo se-aplastic anemia. Uya eNdiya lapho eyofakelwa khona i-stem cell. Funda yonke indaba lapha. Mukhtar Mukhtar..